BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO)

CUSIP: 090572207

Q1 2026 13F Holders as of 31 Mar 2026

Type / Class
Equity / Class B Common Stock
Shares outstanding
5,071,025
Total 13F shares
642,088
Share change
+257,491
Total reported value
$178,914,731
Price per share
$278.75
Number of holders
96
Value change
+$71,628,028
Number of buys
42
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 090572207?
CUSIP 090572207 identifies BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Alice N. Schwartz
3/4/5 13D/G
Director Emeritus, 10%+ Owner
12%
from 13D/G
11,862,229
mixed-class rows
$3,592,267,092 26 Aug 2024
Steven D. Schwartz
3/4/5
10%+ Owner
mixed-class rows
8,560,438
mixed-class rows
$2,584,683,847 26 Aug 2024
Norman D. Schwartz
13D/G 3/4/5
Chairman & CEO, Director, 10%+ Owner
97%
4,929,036
$1,382,052,897 $0 25 Sep 2025
First Eagle Investment Management, LLC
13F 13D/G
Company
11%
from 13D/G
2,570,473
$778,827,760 31 Dec 2025
VANGUARD GROUP INC
13F 13D/G
Company · The Vanguard Group - 23-1945930
8.4%
from 13D/G
1,774,263
$537,583,947 31 Dec 2025
BlackRock, Inc.
13F 13D/G
Company
7.4%
from 13D/G
1,680,948
$509,310,344 31 Dec 2025
DIMENSIONAL FUND ADVISORS LP
13F
Company
21%
1,077,072
$326,343,765 31 Dec 2025
13F
ARIEL INVESTMENTS, LLC
13F
Company
15%
764,672
$231,687,970 31 Dec 2025
13F
EARNEST PARTNERS LLC
13F
Company
12%
603,594
$182,882,946 31 Dec 2025
13F
STATE STREET CORP
13F
Company
11%
559,604
$169,554,416 31 Dec 2025
13F
Veritas Asset Management LLP
13F
Company
11%
543,335
$164,625,072 31 Dec 2025
13F
Capital Research Global Investors
13F
Company
9.8%
494,472
$149,820,071 31 Dec 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
8.8%
445,449
$134,966,592 31 Dec 2025
13F
First Pacific Advisors, LP
13F
Company
7.9%
401,457
$121,637,456 31 Dec 2025
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
7.9%
399,207
$120,955,730 31 Dec 2025
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
7.8%
395,077
$119,704,381 31 Dec 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
6.7%
338,328
$102,531,269 31 Dec 2025
13F
SEI INVESTMENTS CO
13F
Company
5.8%
291,914
$88,445,447 31 Dec 2025
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
5.1%
259,577
$78,649,137 31 Dec 2025
13F
PARNASSUS INVESTMENTS, LLC
13F
Company
5%
252,140
$76,395,899 31 Dec 2025
13F
Boston Partners
13F
Company
4.9%
247,612
$75,037,041 31 Dec 2025
13F
Mawer Investment Management Ltd.
13F
Company
4.6%
233,946
$70,883,299 31 Dec 2025
13F
SOUTHEASTERN ASSET MANAGEMENT INC/TN/
13F
Company
4.5%
227,630
$68,969,614 31 Dec 2025
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
4.5%
226,070
$68,496,949 31 Dec 2025
13F
UBS Group AG
13F
Company
mixed-class rows
216,194
mixed-class rows
$65,504,585 31 Dec 2025
13F
NORTHERN TRUST CORP
13F
Company
4.3%
216,171
$65,497,651 31 Dec 2025
13F
THOMPSON SIEGEL & WALMSLEY LLC
13F
Company
3.8%
191,961
$58,162,000 31 Dec 2025
13F
MORGAN STANLEY
13F
Company
mixed-class rows
187,084
mixed-class rows
$56,682,113 31 Dec 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3.6%
180,389
$54,656,063 31 Dec 2025
13F
GW&K Investment Management, LLC
13F
Company
3.5%
177,083
$53,655,000 31 Dec 2025
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
3.3%
165,107
$50,025,770 31 Dec 2025
13F
FRANKLIN RESOURCES INC
13F
Company
2.7%
137,217
$41,575,380 31 Dec 2025
13F
Fisher Asset Management, LLC
13F
Company
2.6%
131,094
$39,720,169 31 Dec 2025
13F
Allspring Global Investments Holdings, LLC
13F
Company
2.5%
129,211
$39,444,242 31 Dec 2025
13F
Bank of New York Mellon Corp
13F
Company
2.6%
129,354
$39,192,950 31 Dec 2025
13F
MANGROVE PARTNERS IM, LLC
13F
Company
2.5%
126,853
$38,435,190 31 Dec 2025
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
2.4%
122,574
$37,145,924 31 Dec 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
2.4%
120,634
$36,541,000 31 Dec 2025
13F
Gotham Asset Management, LLC
13F
Company
2.3%
117,018
$35,455,284 31 Dec 2025
13F
NORGES BANK
13F
Company
2.3%
114,194
$34,599,640 31 Dec 2025
13F
FEDERATED HERMES, INC.
13F
Company
2.2%
113,929
$34,519,347 31 Dec 2025
13F
Tikvah Management LLC
13F
Company
2.2%
111,084
$33,657,341 31 Dec 2025
13F
Freestone Grove Partners LP
13F
Company
2.2%
110,524
$33,487,667 31 Dec 2025
13F
Allianz Asset Management GmbH
13F
Company
2.2%
110,204
$33,390,710 31 Dec 2025
13F
ENVESTNET ASSET MANAGEMENT INC
13F
Company
1.9%
94,533
$28,642,677 31 Dec 2025
13F
JNE Partners LLP
13F
Company
1.8%
92,100
$27,905,379 31 Dec 2025
13F
Boston Trust Walden Corp
13F
Company
1.8%
89,838
$27,220,016 31 Dec 2025
13F
QVIDTVM Management LLC
13F
Company
1.6%
83,483
$25,294,514 31 Dec 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
1.5%
76,271
$23,110,000 31 Dec 2025
13F
JANE STREET GROUP, LLC
13F
Company
1.5%
73,967
$22,411,262 31 Dec 2025
13F

Institutional Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q1 2026

As of 31 Mar 2026, BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) was held by 96 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 642,088 shares. The largest 10 holders included Assenagon Asset Management S.A., Boston Trust Walden Corp, Hosking Partners LLP, SG Americas Securities, LLC, EXCHANGE TRADED CONCEPTS, LLC, Marathon Asset Management Ltd, Nuveen, LLC, Retirement Systems of Alabama, NEW YORK STATE TEACHERS RETIREMENT SYSTEM, and HSBC HOLDINGS PLC. This page lists 110 institutional shareholders reporting positions in this security for the Q1 2026 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders
393
Q1 2026 holders
96
Holder diff
-297
Investor Q4 2025 Shares Q1 2026 Shares Share Diff Share Chg % Q4 2025 Value $ Q1 2026 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .